These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9017120)

  • 21. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seminal plasma proteins of fertile and infertile men analyzed by two-dimensional electrophoresis.
    Ayyagari RR; Fazleabas AT; Dawood MY
    Am J Obstet Gynecol; 1987 Dec; 157(6):1528-33. PubMed ID: 3425658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
    Mosesson MW
    Thromb Haemost; 2003 Jan; 89(1):9-12. PubMed ID: 12540947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seminal thrombin-activatable fibrinolysis inhibitor: a regulator of liquefaction.
    Lwaleed BA; Goyal A; Greenfield RS; Cooper AJ
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):449-54. PubMed ID: 17581319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.
    Kolev K; Léránt I; Skopál J; Kelemen A; Nagy Z; Machovich R
    Thromb Haemost; 2005 Jul; 94(1):82-7. PubMed ID: 16113788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma.
    Liang ZG; Kamada M; Koide SS
    Biochem Biophys Res Commun; 1991 Oct; 180(1):356-9. PubMed ID: 1930232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine seminal platelet-activating factor acetylhydrolase: association properties in seminal plasma and with lipoproteins.
    Soubeyrand S; Thérien I; Manjunath P
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):176-84. PubMed ID: 9630618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple inhibitory kinetics reveal an allosteric interplay among thrombin functional sites.
    Zavyalova E; Kopylov A
    Thromb Res; 2015 Jan; 135(1):212-6. PubMed ID: 25467079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
    Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
    Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibited thrombins. Interactions with fibrinogen and fibrin.
    Kaminski M; McDonagh J
    Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of semen in cervicovaginal secretions.
    Haimovici F; Anderson DJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):236-8. PubMed ID: 7859134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency in major high molecular-weight seminal proteins in men producing poorly coagulating and alkaline liquid ejaculates.
    Mandal A; Bhattacharyya AK
    Int J Androl; 1992 Aug; 15(4):308-19. PubMed ID: 1516980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors on an elastase-like enzyme activity catalyzing Suc-Ala-Ala-Pro-Leu-pNA amidolysis in human seminal plasma.
    Matsuda Y; Katayama M; Hara I; Sato H; Tomomasa H; Iizumi T; Umeda T; Ishikawa H
    Arch Androl; 2000; 44(1):1-9. PubMed ID: 10690759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human seminal vesicle-specific antigen during semen liquefaction.
    McGee RS; Herr JC
    Biol Reprod; 1987 Sep; 37(2):431-9. PubMed ID: 3676397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
    J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.